In vitro and in vivo evaluation of the antihypertensive drug atenolol in cultured human lymphocytes: Effects of long-term therapy

Mutagenesis

Volumn 15, Issue 3, 2000, Pages 195-202

  Télez, Mercedes ^a   Martínez, Begoña ^a   Criado, Begoña ^b   Lostao, Carlos M ^a   Peñagarikano, Olga ^a   Ortega, Begoña ^a   Flores, Piedad ^a   Ortiz Lastra, Eduardo ^a   Alonso, Rosa M ^a   Jiménez, Rosa M ^a   Arrieta, Isabel ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; CHROMOSOME LOSS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DRUG BLOOD LEVEL; DRUG SENSITIVITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC VARIABILITY; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LONG TERM EXPOSURE; LYMPHOCYTE CULTURE; MALE; MICRONUCLEUS; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

EID: 0343238859     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/15.3.195     Document Type: Article

References (82)

1. Aardema, M.J., Albertini, S., Arni, P., Henderson, L.M., Kirsch-Volders, M., Mackay, J.M., Sarrif, A.M., Stringer, D.A. and Taalman, R.D.F. (1998) Aneuploidy: a report of an ECETOC task force. Mutat. Res., 410, 3-79.
2. Aaron, C.S., Harbach, P.R., Mattano, S.S., Mayo, J.K., Wang, Y., Yu, R.L. and Zimmer, D.M. (1993) Risk and benefit evaluation in development of pharmaceutical products. Environ. Health Perspect., 101, 291-295.
3. Anderson, D. (1999) Factors contributing to biomarker responses in exposed workers. Mutat. Res., 428, 197-202.
4. Andreassi, M.G., Picano, E., Del Ry, S., Petrozzi, L., Giannessi, D. and Varga, A. (1999) Effects of chronic long-term therapy with calcium antagonists on cytogenetic damage in humans. J. Hypertens., 17, 843-846.
5. Arrieta, I., Martínez, B., Criado, B., Lobato, N. and Lostao, C.M. (1992) Genetic and dermatoglyphic distances among Basque valleys. Hum. Biol., 64, 705-717.
6. Arrieta, I., Martínez, B., Núñez, T., Gil, A., Criado, B., Télez, M. and Lostao, C.M. (1995) a-b ridge-count in a Basque population: fluctuating asymmetry and comparison with other populations. Hum. Biol., 67, 121-133.
7. Aruna, N. and Krishnamurthy, N.B. (1986) Mutagenic evaluation of propanolol in somatic and germ cells of mice. Mutat. Res., 173, 207-210.
8. Awara, W.M., El-Gohary, M., El-Nabi, S.H. and Fadel, W.A. (1998) In vivo and in vitro evaluation of the mutagenic potential of carbamazepine: does melatonin have anti-mutagenic activity? Toxicology, 125, 45-52.
9. Bigatti, M.P., Corona, D. and Munizza, C. (1998) Increased sister chromatid exchanges and chromosomal aberration frequencies in psychiatric patients receiving psychopharmacological therapy. Mutat. Res., 413, 169-175.
10. Carrano, A.V. and Natarajan, A.T. (1988) ICPEMC publication No. 14. Considerations for population monitoring using cytogenetic techniques. Mutat. Res., 204, 379-406.
11. Cavalli-Sforza, L.L. and Piazza, A. (1993) Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur. J. Hum. Genet., 1, 3-18.
12. Cimini, D., Tanzarella, C. and Degrassi, F. (1996) Effects of 5-azacytidine on the centromeric region of human fibroblasts studied by CREST staining and in situ hybridization on cytokinesis-blocked cells. Cytogtnet. Cell Genet., 72, 219-224.
13. Degrassi, F. and Tanzarella, C. (1988) Immunofluorescent staining of kinetochores in micronuclei: a new assay for the detection of aneuploidy. Mutat. Res., 203, 339-345.
14. Di Giorgio, C., De Méo, M.P., Laget, M., Guiraud, H., Botta, A. and Duménil, G. (1994) The micronucleus assay in human lymphocytes: screening for inter-individual variability and application to biomonitoring. Carcinogenesis, 15, 313-317.
15. Duffaud, F., Orsière, T., Villani, P., Pelissier, A.L., Volot, F., Favre, R. and Botta, A. (1997) Comparison between micronucleated lymphocyte rates observed in healthy subjects and cancer patients. Mutagenesis, 12, 227-231.
16. Eastmond, D.A. and Tucker, J.D. (1989) Identification of aneuploidy-inducing agents using cytokinesis blocked human lymphocytes and an antikinetochore antibody. Environ. Mol. Mutagen., 13, 34-43.
17. Eastmond, D.A., Schuler, M. and Rupa, M.S. (1995) Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutat. Res., 348, 153-162.
18. Erexson, G.L., Bryant, M.F., Kwanyuen, P. and Kligerman, A.D. (1995) Bleomycin sulfate-induced micronuclei in human, rat and mouse peripheral blood lymphocytes. Environ. Mol. Mutagen., 25, 31-36.
19. Farmer, P.B., Sepai, O., Lawrence, R., Autrup, H., Sabro Nielsen, P., Vestergard, A.B., Waters, R., Leuratti, C., Jones, N.J., Stone, J., Baan, R.A., van Delft, J.H.M., Steenwinkel, M.J.S.T., Kyrtopoulos, S.A., Souliotis, V.L., Theodorakopoulos, N., Bacalis, N.C., Natarajan, A.T., Tates, A.D., Haugen, A., Andreassen, A., Ovrebo, S., Shuker, D.E.G., Amaning, K.S., Schouft, A., Ellul, A., Garner, R.C., Dingley, K.H., Abbondandolo, A., Merlo, F., Cole, J., Aldrich, K., Beare, D., Capulas, E., Rowley, G., Waugh, A.P.W., Povey, A.C., Haque, K., Kirsch-Volders, M., van Hummelen, P. and Castelain, P. (1996) Biomonitoring human exposure to environmental carcinogenic chemicals. Mutagenesis, 11, 363-381.
20. Fenech, M. (1993) The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res., 285, 35-44.
21. Fenech, M. (1998) Important variables that influence base-line micronucleus frequency in cytokinesis-blocked lymphocytes: a biomarker for DNA damage in human populations. Mutat. Res., 404, 155-165.
22. Fenech, M. and Morley, A.A. (1985) Measurement of micronuclei in lymphocytes. Mutat. Res., 147, 29-36.
23. Fitzgerald, J.D. (1979) Atenolol. In Goldberg, M.E. (ed.) Pharmacological and Biochemical Properties of Drug Substances. American Pharmaceutical Association, Washington, DC, Vol. 2, pp. 98-147.
24. Gasiorowski, K., Szyba, K., Wozniak, D. and Gulanowski, B. (1997) Inhibition of potassium dichromate mutagenicity by todralazine. Mutagenesis, 12, 411-415.
25. Giri, A.K., Adhikari, N. and Khan, K.A. (1996) Comparative genotoxicity of six salicylic acid derivatives in bone marrow cells of mice. Mutat. Res., 370, 1-9.
26. Grisolia, C.K. and Takahashi, C.S. (1991) Evaluation of mutagenic effect of the antihypertensive drug methyldopa (Aldomet) on mammalian systems in vivo and in vitro and on Allium cepa. Mutat. Res., 259, 127-132.
27. Grummt, T., Grummt, H.J. and Schott, G. (1993) Chromosomal aberrations in peripheral lymphocytes of nurses and physicians handling antineoplastic drugs. Mutat. Res., 302, 19-24.
28. Guttenbach, M., Schakowski, R. and Schmid, M. (1994) Aneuploidy and ageing: sex chromosome exclusion into micronuclei. Hum. Genet., 94, 295-298.
29. 131I exposure: study in hyperthyroidism patients. Mutat. Res., 373, 39-45.
30. Hagmar, L., Bonassi, S., Strömberg, U., Brogger, A., Knudsen, L.E., Norppa, H., Reuterwall, C. and the European Study Group on Cytogenetic Biomarkers and Health (1998) Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res., 58, 4117-4121.
31. Heddle, J.A., Cimino, M.C., Hayashi, M., Romagna, F., Shelby, M.D., Tucker, J.D., Vanparys, P.H. and MacGregor, J.T. (1991) Micronuclei as an index of cytogenetic damage: past, present and future. Environ. Mol. Mutagen., 18, 277-291.
32. Herzog, R. and Leuschner, J. (1995) Experimental studies on the toxicity of diperdipine following oral and parenteral application. Drug Res., 45, 240-245.
33. Jackson, C.D. and Fishbein, L. (1986) A toxicological review of beta-adrenergic blockers. Fundam. Appl. Toxicol., 6, 395-422.
34. Kirkland, D.J., Dresp, J.H., Marshall, R.R., Baumeister, M., Gerloff, C. and Gocke, E. (1992) Normal chromosomal aberration frequencies in peripheral lymphocytes of healthy human volunteers exposed to a maximum daily dose of paracetamol in a double blind study. Mutat. Res., 279, 181-194.
35. Kirsch-Volders, M., Tallon, I., Tanzarella, C., Sgura, A., Hermine, T., Parry, E.M. and Parry, J.M. (1996) Mitotic non-disjunction as a mechanism for in vitro aneuploidy induction by X-rays in primary human cells. Mutagenesis, 11, 307-313.
36. Lambert, B., Hansson, K., Lindsten, J., Sten, M. and Werelius, B. (1976) Bromodeoxyuridine-induced sister chromatid exchanges in human lymphocytes. Hereditas, 83, 163-174.
37. Lamberti, L., Bigatti, P. and Ardito, G. (1983) Cell kinetics and sister chromatid exchange frequency in human lymphocytes. Mutat. Res., 120, 193-199.
38. Lanza, A., della Cuna, F.S.R., Zibera, C., Pedrazzoli, P. and della Cuna, G.R. (1999) Somatic mutations at the T-cell antigen receptor in antineoplastic drug-exposed populations: comparison with sister chromatid exchange frequency. Int. Arch. Occup. Environ. Health, 428, 197-202.
39. Latt, S.A., Allen, J., Bloom, S.E., Carrano, A., Falke, E., Kram, D., Schneider, E., Schreck, R., Tice, R., Whitfield, B. and Wolff, S. (1981) Sister chromatid exchanges: a report of the Gene-Tox program. Mutat. Res., 87, 17-62.
40. Martelli, A., Canonero, R., Allavena, A., Sottofattori, E. and Brambilla, G. (1992) In vitro and in vivo evaluation of the genotoxicity of N-nitrosooxprenolol. Pharmacol. Toxicol., 71, 154-158.
41. Martelli, A., Allavena, A., Campart, G.B., Canonero, R., Ghia, M., Mattioli, F., Mereto, E., Robbiano, L. and Brambilla, G. (1995) In vitro and in vivo testing of hydralazine genotoxicity. J. Pharmacol. Exp. Ther., 273, 113-120.
42. Marzin, D. (1997) The position of the in vitro micronucleus test within the battery of screening for genotoxic potential determination and the regulatory guidelines. Mutat. Res., 392, 175-181.
43. McDiarmid, M.A., Kolodner, K., Humphrey, F., Putman, D. and Jacobson, D.K. (1992) Baseline and phosphoramide mustard-induced sister chromatid exchanges in pharmacists handling anti-cancer drugs. Mutat. Res., 279, 199-204.
44. Miele, M., Bonassi, S., Bonatti, S., Martini, E., Miglio, L., Ottaggio, L., Queirolo, P., Sertoli, M.R. and Abbondandolo, A. (1998) Micronucleus analysis in peripheral blood lymphocytes from melanoma patients treated with dacarbazine. Anticancer Res., 18, 1867-1972.
45. Migliore, L., Guidotti, P., Favre, C., Nardi, M., Sessa, M.R. and Brunori, E. (1991) Micronuclei in lymphocytes of young patients under antileukemic therapy. Mutat. Res., 263, 243-248.
46. Migliore, L., Cocchi, L. and Scarpato, R. (1996) Detection of the centromere in micronuclei by fluorescence in situ hybridization: its application to the human lymphocyte micronucleus assay after treatment with four suspected aneugens. Mutagenesis, 11, 285-290.
47. Migliore, L., Testa, A., Scarpato, R., Pavese, N., Petrozzi, L. and Bonuccelli, U. (1997) Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum. Genet., 101, 299-305.
48. Migliore, L., Cocchi, L., Scarpato, R. and Sbrana, I. (1998) Induction of aneuploidy by the antineoplastic drug estramustine in human lymphocytes. Mutat. Res., 412, 33-40.
49. Migliore, L., Martelli, L. and Scarpato, R. (1999) Detection of chromosome loss and gain induced by griseofulvin, estramustine and vanadate in binucleated lymphocytes using FISH analysis. Environ. Mol. Mittagen., 34, 64-68.
50. Miller, B.M., Madle, S. and Albertini, S. (1994) Can a relatively simple screening procedure for the detection of chemicals with aneugenic potential be recommended at the moment? Mutat. Res., 304, 303-307.
51. Miller, B., Pötter-Locher, F., Seelbach, A., Stopper, H., Utesch, D. and Madle, S. (1998) Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM working group on the in vitro micronucleus test. Mutat. Res., 410, 81-116.
52. Monsieurs, M.A., Thierens, H.M., van de Wiele, C., Vral, A.M., Meirlaen, I.A., de Winter, H.A., de Sadeleer, C.J., de Ridder, L.I., Kaufman, J.M. and Dierckx, R.A. (1999) Estimation of risk based on biological dosimetry for patients treated with radioiodine. Nucl. Med. Commun., 20, 911-917.
53. Morimoto, K., Takeshita, T., Take-uchi, T., Maruyama, S.I., Ezoe, S., Mure, K. and Inoue, C. (1993) Chromosome alterations in peripheral lymphocytes as indices of lifestyle and genotoxicity. Int. Arch. Occup. Environ. Health, 65, 37-41.
54. Muller, L., Kasper, P. and Madle, S. (1991) The quality of genotoxicity testing of drugs. Experiences of a regulatory agency with new and old compounds. Mutagenesis, 6, 143-149.
55. Nesterova, E.V., Durnei, A.D. and Seredenin, S.B. (1999) Verapamil contributes to the clastogenic effects of acrylamide, cyclophosphamide and diodixine on somatic cells of BALB/C and C57BL/6 mice. Mutat. Res., 440, 171-179.
56. Nowinski, G.P., Dyke, D.L., van Tilley, B.C., Jacobsen, G., Babu, V.R., Worsham, M.J., Wilson, G.N. and Weiss, L. (1990) The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive history. Am. J. Hum. Genet., 46, 1101-1111.
57. Okine, L.K.N., Ioannides, C. and Parke, D.V. (1983) Studies on the possible mutagenicity of beta-adrenergic blocker drugs. Toxicol. Lett., 16, 167-174.
58. Parry, E.M., Henderson, L. and Mackay, J.M. (1995) Procedures for the detection of chemically induced aneuploidy: recommendations of a UK Environmental Mutagen Society working group. Mutagenesis, 10, 1-14.
59. Perry, P. and Wolff, S. (1974) New Giemsa method for the differential staining of sister chromatids. Nature, 251, 156-158.
60. Presta, M., Mazzocchi, C. Ziliani, S. and Ragnotti, G. (1983) In vitro and in vivo DNA damage of male and female rat liver nuclei by oncogenic and non-oncogenic beta blockers. J. Natl Cancer Inst., 70, 747-752.
61. Prieto, M., de Abajo, F.J., Montero, D., Martín, G., Madurga, M. and Palop, R. (1998) Uso de antihipertensivos en España. 1985-1995. Med. Clin. Barcelona, 110, 247-253.
62. Purves, D., Harvey, C., Tweats, D. and Lumley, C.E. (1995) Genotoxicity testing: current practices and strategies used by the pharmaceutical industry. Mutagenesis, 10, 297-312.
63. Ramírez, M.J., Surrallés, J., Puerto, S., Creus, A. and Marcos, R. (1997) Aneugenic activity in human cultured lymphocytes. An overall study with colchicine using the micronucleus assay and fluorescence in situ hybridization techniques. Mutagenesis, 12, 405-410.
64. Scarpato, R., Landini, E. and Migliore, L. (1996) Acrocentric chromosome frequency in spontaneous human lymphocyte micronuclei, evaluated by dual-colour hybridization, is neither sex-nor age-related. Mutat. Res., 372, 195-204.
65. Stone, J.F. and Sandberg, A.A. (1995) Sex chromosome aneuploidy and aging. Mutat. Res., 338, 107-113.
66. Surrallés, J. and Natarajan, A.T. (1997) Human lymphocytes micronucleus assay in Europe. An international survey. Mutat. Res., 392, 165-174.
67. Surrallés, J., Carbonell, E., Marcos, R., Degrassi, F., Antoccia, A. and Tanzarella, C. (1992) A collaborative study on the improvement of the micronucleus test in cultured human lymphocytes. Mutagenesis, 7, 407-410.
68. Surrallés, J., Antoccia, A., Creus, A., Degrassi, F., Peris, F., Tanzarella, C., Xamena, N. and Marcos, R. (1994) The effect of cytochalasin B concentration on the frequency of micronuclei induced by four standard mutagens. Results from two laboratories. Mutagenesis, 9, 347-353.
69. Thierens, H., Vral, A., Barbe, M., Aousalah, B. and de Ridder, L. (1999) A cytogenetic study of nuclear power plant workers using the micronucleus-centromere assay. Mutat. Res., 445, 105-111.
70. Tsutsui, T., Taguchi, S., Hasegawa, K., Ide, T., Kojima, K., Matsumura, M., Huff, J. and Barrett, J.C. (1994) Reserpine-induced cell transformation without detectable genetic effects in Syrian hamster embryo cells in culture. Carcinogenesis, 15, 11-14.
71. Tucker, J.D. and Preston, R.J. (1996) Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges and cancer risk assessment. Mutat. Res., 365, 147-159.
72. Tucker, J.D., Eastmond, D.A. and Littlefield, L.G. (1997) Cytogenetic endpoints as biological dosimeters and predictors of risk in epidemiological studies. In Toniolo, P., Boffetta, P., Shuker, D.E.G., Rothman, N., Hulka, B. and Pearce, N. (eds) Application of Biomarkers in Cancer Epidemiology. IARC Scientific Publications no. 142. IARC, Lyon, pp. 185-200.
73. Tusell, L., Alvarez, R., Genescà, A., Caballìn, M.R., Miró, R. and Egozcue, J. (1996) Analysis of radiation-induced micronuclei in two-cell human-hamster embryos using telomeric and cemromeric FISH probes. Cytogenet. Cell Genet., 74, 102-106.
74. van Asten, P., Darroudi, F., Natarajan, A.T., Terpstra, I.J. and Duursma, S.A. (1998) Cytogenetic effects on lymphocytes in osteoporotic patients on long-term fluoride therapy. Pharm. World Sci., 20, 214-218.
75. van Delft, J.H.M., Baan, R.A. and Roza, L. (1998) Biological effect markers for exposure to carcinogenic compound and their relevance for risk assessment. Crit. Rev. Taxicol., 28, 477-510.
76. Vanderkerken, K., Vanparys, P.H., Verschaeve, L. and Kirsch-Volders, M. (1989) The mouse bone marrow micronucleus assay can be used to distinguish aneugens from clastogens. Mutagenesis, 4, 6-11.
77. Vlastos, D. and Stephanou, G. (1998) Effects of cetirizine dihydrochloride on human lymphocytes in vitro: micronucleus induction. Evaluation of clastogenic and aneugenic potential using CREST and FISH assays. Arch. Dermatol. Res., 290, 312-318.
78. Vlastos, D., Stephanou, G. and Demopoulos, N.A. (1998) Effects of cetirizine dihydrochloride on human lymphocytes in vitro: evaluation of chromosome aberrations and sister chromatid exchanges. Skin Pharmacol. Appl. Skin Physiol., 11, 104-110.
79. Wadworth, A.N., Murdoch, D. and Brogden, R.N. (1991) Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs, 42, 469-510.
80. Wolff, S. (1998) Chromosomes in the assessment of the effects of low levels of genotoxic agents. Hum. Exp. Toxicol., 17, 625-632.
81. Yamamoto, K.I. and Kikuchi, Y. (1980) A comparison of diameters of micronuclei induced by clastogens and by the spindle poisons. Mutat. Res., 71, 127-131.
82. Zijno, A., Leopardi, P., Marcon, F. and Crebelli, R. (1996) Analysis of chromosome segregation by means of fluorescence in situ hybridization: application to cytokinesis-blocked human lymphocytes. Mutat. Res., 372, 211-219.